The Effects of Muscle Characteristics on the Control of Shoulder Complex

Status Recruiting

Clinical Trial Summary

The movement control of shoulder joint relies not only on the glenohumeral joint, but also the critical contributions from scapulothoracic joint. The relating scapula muscle strength, scapula mobility and, the most important of all, the capacity of neuromuscular control should be integrated into the rehabilitation program for patients with shoulder disorders. With regarding to the subacromial impingement syndrome or rotator tendinopathy, the status of scapula dyskinesia and dysfunctions were improved significantly after the intervention of scapula-emphasized exercise. But there was no study addressed the relationships between stiffness of relating muscles and the deficits of scapula movement. The stiffness had been shown to serve an important role in functional performance of the corresponding joint. For example, the decreased elasticity of supraspinatus muscle was noticed on affected side comparing in patients with impingement syndrome.Few studies examined the effects of altered muscle stiffness on kinematic performance in shoulder complex. Laudner et al. found that the stiffer the latismuss dorsi muscle was, the less upward rotation and posterior tilting, and the more internal rotation of scapula during arm elevation was exhibited in asymptomatic swimmers. Another study showed that the increased range of external rotation and posterior tilt of scapula during arm elevation were associated with the decreased stiffness of pectoralis minor. The recent study presented that the electromyographic activities and elasticities of middle deltoid, supraspinatus, and infraspinatus muscles correlated significantly with the tissue elasticity during shoulder movement in healthy shoulder. However, there was no scientific information directly to prove the changes in characteristics of rotator cuff function as well as the impacts on kinematic control of shoulder complex. Therefore, the aim of this study is to examine the relationship among characteristics of muscle properties and kinematic control healthy swimmers.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Disease
Joint Instability
Movement Disorders
Other Instability of Joint, Shoulder Region
Strain of Shoulder Muscle (Disorder)

Clinical Trial Details

NCT number	NCT04176692
Study type	Observational
Source	Tzu Chi University
Contact	Po-Tsun Chen
Phone	886-3-856-5301
Email	ptchen120@mail.tcu.edu.tw
Status	Recruiting
Phase
Start date	September 1, 2019
Completion date	August 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05623644` - Multimodal MR Imaging Study on ET and PD Patients Subjected With MRgFUS Thalamotomy
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Completed	`NCT03295786` - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease	Phase 1/Phase 2
Completed	`NCT03722212` - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test	N/A
Recruiting	`NCT05973929` - Movement Disorders in Multiple Sclerosis Patients
Terminated	`NCT02823158` - Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM	N/A
Enrolling by invitation	`NCT01210781` - Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation
Enrolling by invitation	`NCT00355927` - Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.	N/A
Completed	`NCT00037167` - Effects of Exercise Poles on Older Adults During Exercise Walking	Phase 1/Phase 2
Recruiting	`NCT04784494` - MST for Parkinson's Disease	N/A
Terminated	`NCT03270189` - Effect of the Visual Information Change in Functional Dystonia	N/A
Recruiting	`NCT04061135` - Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders	N/A
Suspended	`NCT04912115` - Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia	Phase 2
Completed	`NCT00500994` - Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures	Early Phase 1
Completed	`NCT04536987` - Robot Therapy for Rehabilitation of Hand Movement After Stroke	Phase 2
Recruiting	`NCT00001208` - Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Not yet recruiting	`NCT05560269` - Verbal Cueing vs. Constraint-Led Approach for Teaching the Kettlebell Swing.	N/A
Completed	`NCT02392078` - Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Completed	`NCT00552474` - Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease	N/A
Not yet recruiting	`NCT05032911` - Sensorimotor Control in People With and Without Neck Pain

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effects of Muscle Characteristics on the Control of Shoulder Complex During Functional Movements

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms